Effect of the herbal mixture composed of Aloe Vera, Henna, Adiantum capillus-veneris, and Myrrha on wound healing in streptozotocin-induced diabetic rats

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Galehdari, Hamid ^a   Negahdari, Samira ^b   Kesmati, Mahnaz ^b   Rezaie, Anahita ^c   Shariati, Gholamreza ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

^c SHAHID CHAMRAN UNIVERSITY OF AHVAZ   (Iran)

Author keywords

Diabetic; Herbal remedies; Matrix metalloproteases; Wound healing

Indexed keywords

ADIANTUM CAPILLUS VENERIS EXTARCT; ALOE VERA EXTRACT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; COMMIPHORA MOLMOL EXTARCT; GELATINASE B; INTERLEUKIN 6; LAWSONIA INERMIS EXTRACT; PETROLATUM; PLANT EXTRACT; STREPTOZOCIN; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; MATRIX METALLOPROTEINASE;

ADIANTUM; ADIANTUM CAPILLUS VENERIS; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COMMIPHORA; CONTROLLED STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MMP3 GENE; NONHUMAN; PLANT LEAF; RAT; REAL TIME POLYMERASE CHAIN REACTION; TGFB1 GENE; TNFA GENE; TRADITIONAL MEDICINE; WOUND HEALING; ALOE; ANIMAL; CHEMISTRY; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION; LAWSONIA INERMIS; METABOLISM; WISTAR RAT;

ADIANTUM; ALOE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; LAWSONIA PLANT; MALE; MATRIX METALLOPROTEINASES; PLANT EXTRACTS; RATS; RATS, WISTAR; WOUND HEALING;

EID: 84991261656     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1359-7     Document Type: Article

References (76)

1. Chithra P, Sajithlal GB, Chandrakasan G. Influence of aloe vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol. 1998;59(3):195-201.
2. Babaei S, Bayat M, Nouruzian M. Pentoxifylline improves cutaneous wound healing in streptozotocin-induced diabetic rats. Eur J Pharmacol. 2012;700(1-3):165-72.
3. Blakytny R, Jude E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006;23(6):594-608.
4. Darby IA, et al. Apoptosis is increased in a model of diabetes-impaired wound healing in genetically diabetic mice. Int J Biochem Cell Biol. 1997;29(1):191-200.
5. Zheng L, et al. Matrix metalloproteinase-3 accelerates wound healing following dental pulp injury. Am J Pathol. 2009;175(5):1905-14.
6. Ravanti L, Kahari VM. Matrix metalloproteinases in wound repair (review). Int J Mol Med. 2000;6(4):391-407.
7. Galko MJ, Krasnow MA. Cellular and genetic analysis of wound healing in Drosophila larvae. PLoS Biol. 2004;2(8):E239.
8. Frankwich K, et al. Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes. J Inflamm (Lond). 2012;9(1):35.
9. Gutierrez-Fernandez A, et al. Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J. 2007;21(10):2580-91.
10. Rodrigues SF, et al. Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2010;299(1):H25-35.
11. McLennan SV, Martell SY, Yue DK. High glucose concentration inhibits the expression of membrane type metalloproteinase by mesangial cells: possible role in mesangium accumulation. Diabetologia. 2000;43(5):642-8.
12. McLennan SV, et al. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy. Diabetes. 1994;43(8):1041-5.
13. Lobmann R, et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 2002;45(7):1011-6.
14. Barrientos S, et al. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601.
15. Badr G, et al. Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1alpha, MIP-2, KC, CX3CL1 and TGF-beta in wounded tissue. BMC Immunol. 2012;13:32.
16. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83(3):835-70.
17. Penn JW, Grobbelaar AO, Rolfe KJ. The role of the TGF-beta family in wound healing, burns and scarring: a review. Int J Burns Trauma. 2012;2(1):18-28.
18. Pastar I, et al. Attenuation of the transforming growth factor beta-signaling pathway in chronic venous ulcers. Mol Med. 2010;16(3-4):92-101.
19. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007;117(5):1219-22.
20. Hosein Farzaei M, et al. A comprehensive review of plants and their active constituents with wound healing activity in traditional Iranian medicine. Wounds. 2014;26(7):197-206.
21. Prasad V, Dorle AK. Evaluation of ghee based formulation for wound healing activity. J Ethnopharmacol. 2006;107(1):38-47.
22. Atiba A, Ueno H, Uzuka Y. The effect of aloe vera oral administration on cutaneous wound healing in type 2 diabetic rats. J Vet Med Sci. 2011;73(5):583-9.
23. Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol. 1990;28(2):215-20.
24. Morgan C, Nigam Y. Naturally derived factors and their role in the promotion of angiogenesis for the healing of chronic wounds. Angiogenesis. 2013;16(3):493-502.
25. Vijayalakshmi D, et al. In vitro anti inflammatory activity of Aloe vera by down regulation of MMP-9 in peripheral blood mononuclear cells. J Ethnopharmacol. 2012;141(1):542-6.
26. Atiba A, Ueno H, Uzuka Y. The effect of aloe vera oral administration on cutaneous wound healing in type 2 diabetic rats. J Vet Med Sci. 2010;73(5):583-9.
27. Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on collagen characteristics in healing dermal wounds in rats. Mol Cell Biochem. 1998;181(1-2):71-6.
28. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep. 2005;57(1):90-6.
29. Nomicos EY. Myrrh: medical marvel or myth of the Magi? Holist Nurs Pract. 2007;21(6):308-23.
30. Massoud A, El Sisi S, Salama O. Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). Am J Trop Med Hyg. 2001;65(2):96-9.
31. Fraternale D, et al. Anti-inflammatory, antioxidant and antifungal furanosesquiterpenoids isolated from Commiphora erythraea (Ehrenb.) Engl. resin. Fitoterapia. 2011;82(4):654-61.
32. Abdul-Ghani RA, Loutfy N, Hassan A. Myrrh and trematodoses in Egypt: an overview of safety, efficacy and effectiveness profiles. Parasitol Int. 2009;58(3):210-4.
33. Tonkal AM, Morsy TA. An update review on Commiphora molmol and related species. J Egypt Soc Parasitol. 2008;38(3):763-96.
34. Lotfy M, et al. Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus. Br J Biomed Sci. 2006;63(4):171-3.
35. Ishaq MS, et al. In vitro phytochemical, antibacterial, and antifungal activities of leaf, stem, and root extracts of Adiantum capillus veneris. Sci World J. 2014;2014:269793.
36. Nilforoushzadeh MA, et al. The Effects of Adiantum capillus-veneris on Wound Healing: An Experimental In Vitro Evaluation. Int J Prev Med. 2014;5(10):1261-8.
37. Nayak BS, et al. The evidence based wound healing activity of Lawsonia inermis Linn. Phytother Res. 2007;21(9):827-31.
38. Mikhaeil BR, et al. Antioxidant and immunomodulatory constituents of henna leaves. Z Naturforsch C. 2004;59(7-8):468-76.
39. Sternlicht MD, Bissell MJ, Werb Z. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene. 2000;19(8):1102-13.
40. Cohen M, Meisser A, Bischof P. Metalloproteinases and human placental invasiveness. Placenta. 2006;27(8):783-93.
41. Sautter NB, et al. Tissue remodeling in the acute otitis media mouse model. Int J Pediatr Otorhinolaryngol. 2011;75(11):1368-71.
42. Bullard KM, et al. Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg. 1999;230(2):260-5.
43. Kowluru RA. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest Ophthalmol Vis Sci. 2010;51(8):4320-6.
44. Min D, et al. Activation of macrophage promatrix metalloproteinase-9 by lipopolysaccharide-associated proteinases. J Immunol. 2002;168(5):2449-55.
45. Liu Y, et al. Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers. Diabetes Care. 2009;32(1):117-9.
46. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet. 2005;366(9498):1736-43.
47. Lockwood CJ, et al. Matrix metalloproteinase 9 (MMP9) expression in preeclamptic decidua and MMP9 induction by tumor necrosis factor alpha and interleukin 1 beta in human first trimester decidual cells. Biol Reprod. 2008;78(6):1064-72.
48. Van den Steen PE, et al. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002;37(6):375-536.
49. Lin ZQ, et al. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol. 2003;73(6):713-21.
50. Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8(9):1254-66.
51. Gallucci RM, et al. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 2000;14(15):2525-31.
52. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19(3):433-42.
53. Agrawal NK, Kant S. Targeting inflammation in diabetes: Newer therapeutic options. World J Diabetes. 2014;5(5):697-710.
54. Gill SE, Parks WC. Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol. 2008;40(6-7):1334-47.
55. Zhou M, et al. Interferon-gamma differentially regulates monocyte matrix metalloproteinase-1 and -9 through tumor necrosis factor-alpha and caspase 8. J Biol Chem. 2003;278(46):45406-13.
56. Nguyen J, et al. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes. Immunol Lett. 2006;106(1):34-41.
57. Xu F, Zhang C, Graves DT. Abnormal cell responses and role of TNF-alpha in impaired diabetic wound healing. Biomed Res Int. 2013;2013:754802.
58. Werner S, Krieg T, Smola H. Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol. 2007;127(5):998-1008.
59. Liu R, et al. Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol. 2006;168(3):757-64.
60. Lamers ML, et al. High glucose-mediated oxidative stress impairs cell migration. PLoS One. 2011;6(8):e22865.
61. Assoian RK, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem. 1983;258(11):7155-60.
62. Wu XB, et al. The effects of Polygonum cuspidatum extract on wound healing in rats. J Ethnopharmacol. 2012;141(3):934-7.
63. Wang XJ, et al. Role of TGF beta-mediated inflammation in cutaneous wound healing. J Investig Dermatol Symp Proc. 2006;11(1):112-7.
64. Brown RL, et al. Wound healing in the transforming growth factor-beta-deficient mouse. Wound Repair Regen. 1995;3(1):25-36.
65. Dolara P, et al. Local anaesthetic, antibacterial and antifungal properties of sesquiterpenes from myrrh. Planta Med. 2000;66(4):356-8.
66. Manjula N, et al. Inhibition of MAP kinases by crude extract and pure compound isolated from Commiphora mukul leads to down regulation of TNF-alpha, IL-1beta and IL-2. Int Immunopharmacol. 2006;6(2):122-32.
67. Choi SW, et al. The wound-healing effect of a glycoprotein fraction isolated from aloe vera. Br J Dermatol. 2001;145(4):535-45.
68. Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacology. 1996;35(2):119-28.
69. Tanaka M, et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull. 2006;29(7):1418-22.
70. Jettanacheawchankit S, et al. Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type I collagen; and wound healing. J Pharmacol Sci. 2009;109(4):525-31.
71. Kirkland D, Marzin D. An assessment of the genotoxicity of 2-hydroxy-1,4-naphthoquinone, the natural dye ingredient of Henna. Mutat Res. 2003;537(2):183-99.
72. Jeyaseelan EC, et al. Antibacterial activity of sequentially extracted organic solvent extracts of fruits, flowers and leaves of Lawsonia inermis L. from Jaffna. Asian Pac J Trop Biomed. 2012;2(10):798-802.
73. Habbal O, et al. Antibacterial activity of Lawsonia inermis Linn (Henna) against Pseudomonas aeruginosa. Asian Pac J Trop Biomed. 2011;1(3):173-6.
74. Askari G, et al. The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. J Res Med Sci. 2012;17(7):637-41.
75. Calderon-Montano JM, et al. A review on the dietary flavonoid kaempferol. Mini Rev Med Chem. 2011;11(4):298-344.
76. Ibraheim ZZ, Ahmed AS, Gouda YG. Phytochemical and biological studies of Adiantum capillus-veneris L. Saudi Pharm J. 2011;19(2):65-74.